{"id":"W2984625937","doi":"10.1182/blood-2019-123433","title":"Final Analysis of GOYA: A Randomized, Open-Label, Phase III Study of Obinutuzumab or Rituximab Plus CHOP in Patients with Previously Untreated Diffuse Large B-Cell Lymphoma","year":2019,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Obinutuzumab; Medicine; Diffuse large B-cell lymphoma; Rituximab; Internal medicine; CHOP; International Prognostic Index; Neutropenia; Gastroenterology; Febrile neutropenia; Oncology; Lymphoma; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003392858,0.001823413,0.003083607,0.0004629748,0.0006114158,0.001568253,0.001295051,0.001905778,0.004441652],"category_scores_gemma":[0.002042539,0.00067762,0.003462856,0.000553065,0.001276125,0.0009885093,0.0006592033,0.003548391,0.0009945683],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001062379,"about_ca_system_score_gemma":0.002531898,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000913879,"about_ca_topic_score_gemma":0.003366057,"domain_scores_codex":[0.9986033,0.0007452559,0.00006510669,0.0002373321,0.0001043892,0.0002446194],"domain_scores_gemma":[0.998525,0.0002723147,0.0003029335,0.0001546601,0.0001569811,0.0005880909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9543083,0.01393642,0.003525636,0.0007199523,0.002917958,0.0001401925,0.000144694,0.0005234051,0.006833375,0.0001648746,0.001425014,0.01536012],"study_design_scores_gemma":[0.8812041,0.1090669,0.006020693,0.00003899567,0.001048014,0.00007627937,0.00003855838,0.0002571229,0.0004547478,0.0001322771,0.001645289,0.00001705043],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9786889,0.0034644,0.0008804999,0.0009238963,0.0003400601,0.01057949,0.002930941,0.000125091,0.00206671],"genre_scores_gemma":[0.9788333,0.001527748,0.002334259,0.001425967,0.0002611329,0.009325161,0.004153062,0.00004118454,0.002098273],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004441652,"threshold_uncertainty_score":0.01794338,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01666141507619155,"score_gpt":0.2813330558796354,"score_spread":0.2646716408034439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}